Posard Matthew L.
Reporting Owner SEC Filing List

CIK: 0001543792
FormFilerSubject CompanyFiling AgentDateActions
4Statement of changes in beneficial owner...Posard Matthew L.05/07/2026
4Statement of changes in beneficial owner...Halozyme Therapeutics, Inc.05/07/2026
4Statement of changes in beneficial owner...Nautilus Biotechnology, Inc.Nautilus Biotechnology, Inc. /fa06/25/2025
4Statement of changes in beneficial owner...Posard Matthew L.Nautilus Biotechnology, Inc. /fa06/25/2025
4Statement of changes in beneficial owner...Posard Matthew L.Sec Connect /fa05/02/2025
4Statement of changes in beneficial owner...Halozyme Therapeutics, Inc.Sec Connect /fa05/02/2025
4Statement of changes in beneficial owner...Posard Matthew L.Sec Connect /fa08/14/2024
4Statement of changes in beneficial owner...Halozyme Therapeutics, Inc.Sec Connect /fa08/14/2024
144Filing for proposed sale of securities u...Posard Matthew L.Ameriprise Financial Services Llc - 116786 /fa08/07/2024
144Filing for proposed sale of securities u...Halozyme Therapeutics, Inc.Ameriprise Financial Services Llc - 116786 /fa08/07/2024
Load More

Posard Matthew L. 's Ownership Transactions

IssuerFiling
Date
Transaction
Date
Transaction
Type
SharesPriceTotal AmtShares Owned